Načítá se...
Intravitreal Controlled Release of Dexamethasone from Engineered Microparticles of Porous Silicon Dioxide
Dexamethasone is a glucocorticoid that is widely used in the ophthalmic arena. The recent FDA approved dexamethasone implant can provide a three month efficacy but with high rate of drug related cataract and high intraocular pressure (IOP). It seems that higher steroid in aqueous humor and around le...
Uloženo v:
| Vydáno v: | Exp Eye Res |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4259850/ https://ncbi.nlm.nih.gov/pubmed/25446320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exer.2014.11.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|